Vegetable Compound May Reduce Mesothelioma Treatment Side EffectsTreatment & Doctors
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
- Assisting mesothelioma patients and their loved ones since 2006.
- Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
- A+ rating from the Better Business Bureau.
- 5-star reviewed mesothelioma and support organization.
"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."LashawnMesothelioma patient’s daughter
How to Cite Asbestos.com’s Article
Rosenberg, J. (2020, October 16). Vegetable Compound May Reduce Mesothelioma Treatment Side Effects. Asbestos.com. Retrieved November 29, 2022, from https://www.asbestos.com/news/2014/12/09/vegetable-compound-reduces-chemotherapy-side-effects/
Rosenberg, Joey. "Vegetable Compound May Reduce Mesothelioma Treatment Side Effects." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/news/2014/12/09/vegetable-compound-reduces-chemotherapy-side-effects/.
Rosenberg, Joey. "Vegetable Compound May Reduce Mesothelioma Treatment Side Effects." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/news/2014/12/09/vegetable-compound-reduces-chemotherapy-side-effects/.
For a cancer as rare and difficult to treat as mesothelioma, innovative thinking is vital to making progress that helps survivors live longer and feel healthier.
While experimental therapies for this disease have harnessed genetically modified viruses, leopard frog eggs and laser-activated drugs, innovation doesn’t always come from exotic sources. Sometimes treatment breakthroughs are hiding in plain sight.
Take the veggies on your dinner plate, for example.
A research team has reported an anti-cancer vegetable compound called PEITC could have interesting therapeutic benefits for pleural mesothelioma patients.
The National Cancer Institute shows PEITC is found in cruciferous vegetables, a nutrient-rich family of plants that includes:
- Bok choy
- Brussels sprouts
- Collard greens
The medical journal Oncotarget recently published an article about a team of French researchers who confirmed for the first time that PEITC and the popular chemotherapy drug cisplatin make a powerful, cancer-fighting pair. While research shows both can kill mesothelioma cells on their own, the study shows they are even more effective when combined.
The study also found the combination is completely safe for healthy cells, suggesting it may have fewer side effects than standard chemotherapy.
Better Treatment Strategies Needed
Standard first-line treatment for mesothelioma involves combined treatment with chemotherapy drugs cisplatin and pemetrexed (Alimta). Several clinical trials show this combination is more effective than cisplatin alone, but the benefits are modest and side effects can be severe. About half of patients respond to that approach.
“Treatment of [pleural mesothelioma] represents a major public health challenge given its aggressiveness, poor prognosis after diagnosis and, more importantly, its lack of effective curative therapies,” Dr. Iza Denis, lead author of the article, said.
After a 2013 study identified the impressive combined effect of cisplatin and PEITC against lung cancer cells, Denis and colleagues sought to determine if the combination could also benefit mesothelioma patients.
Using a technique called the Uptiblue viability assay, researchers tested the compounds on nine mesothelioma cell lines and measured how many cancer cells died after exposure. They exposed the cells to several concentrations of the cisplatin-PEITC combination, as well as each compound on its own.
The experiment confirmed the combination is effective against mesothelioma cells. For one of the three concentrations tested, cisplatin-PEITC killed nearly 80 percent of cells, while each compound killed about 40 percent individually. When researchers increased the dose, more mesothelioma cells died.
Combination Safe for Healthy Cells
Researchers also investigated how the cisplatin-PEITC combination affects healthy cells of the pleura, the protective lining around the lungs where pleural mesothelioma forms. They found the compounds were not toxic to healthy pleural cells, either alone or combined.
The experiment “clearly illustrates the safety of our strategy for healthy cells while inducing almost 100 percent [pleural mesothelioma] cell death,” Denis said. His team concluded it would be safe and feasible to develop cisplatin-PEITC into a local therapy that doctors could inject directly into the space between a patient’s lungs and pleura.
Local therapies, including radiation, target the site of the tumor more precisely than systemic therapies like chemotherapy, which spreads cancer-killing drugs throughout the body. Both approaches can have serious side effects when treatments harm healthy cells, a complication that cisplatin-PEITC avoids.
Cisplatin-PEITC Fights Chemoresistance
One reason patients respond poorly to cisplatin therapy is that cancer cells grow resistant to the drug, which may cause the treatment to fail. This effect is called chemoresistance, and it’s a major challenge for doctors and patients.
In the study, researchers observed that mesothelioma cells develop a resistance to both cisplatin and PEITC when given individually. Combined, however, the compounds remained effective over time and prevented the development of treatment-resistant cells.
“The combination not only led to a significant increase of cell death, but more importantly prevented the emergence of chemoresistance,” Denis said.
Because cisplatin-PEITC is safe, effective and can bypass resistance to chemotherapy, Denis and his research team believe it could be a promising new treatment strategy for mesothelioma.